Description
PRINCIPIO ACTIVO: VALPROATO DE MAGNESIO
Enfermedad cardiaca isquémica establecida
indicado para el tratamiento de neoplasias hematológicas
PRINCIPIO ACTIVO: PARACETAMOL
LARITOL TAB. 10 MG. CAJA C/10 RACECADOTRIL PRINCIPIO ACTIVO: VALPROATO DE MAGNESIOSUSTANCIA: LARITOL TAB. 10 MG. CAJA C 10 FABRICANTE: MAVER
Exchange/Return Notes
- We offer a 30-day return/exchange service after receiving.
- Final sale items are not eligible for returns or exchanges.
- To process your return/exchange, please contact us at [email protected]
- Please click here for more details>>> Return & Exchange Policy
You may also like
recommand products
